Summerset Group (SUM) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 Apr, 2026Opening remarks and agenda
The meeting was held online due to severe weather and flooding in Wellington, ensuring shareholder safety and participation via a virtual platform.
Formalities confirmed: notice of meeting issued, quorum met, and agenda included board and CEO addresses, committee updates, general business, and formal resolutions.
Resolution on director remuneration was withdrawn due to changed circumstances since benchmarking.
Financial performance review
Underlying profit for FY 2025 was NZD 234.2 million, up 13% from the prior year, driven by increased sales and portfolio growth.
Net tangible assets per share rose by NZD 1.32 to NZD 13.75; dividends declared at NZD 0.245 per share, consistent with the prior year.
Gearing at year-end was 37.1%, with NZD 1.97 billion in bank debt and NZD 627 million undrawn capacity.
Net cash from operating activities reached NZD 548.2 million, up from NZD 443.2 million in FY 2024.
IFRS net profit after tax was NZD 260 million, down NZD 70 million due to subdued property market and lower valuation uplift.
Board and executive committee updates
Committee chairs reported on audit and risk, development and construction, clinical governance, and people and culture.
Audit and Risk Committee focused on financial/non-financial reporting, risk management, treasury governance, and internal audit, including climate disclosures.
Development and Construction Committee emphasized project performance, risk governance, supply chain stability, and design improvements.
Clinical Governance Committee highlighted telehealth support, technology trials, and resident engagement initiatives.
People and Culture Committee prioritized remuneration, succession planning, diversity, and employee engagement.
Latest events from Summerset Group
- Record profit, strong sales, and robust growth underpin continued expansion and financial strength.SUM
H2 202526 Feb 2026 - Strong growth, stable dividends, and strategic expansion amid sector and funding challenges.SUM
AGM 202529 Nov 2025 - Record Q3 2025 occupation right sales and robust growth in care agreements drive strong outlook.SUM
Q3 2025 TU10 Oct 2025 - Net profit after tax surged 26% to $127.2m, with record settlements and robust sales momentum.SUM
H1 202527 Aug 2025 - Underlying profit up 3% and record sales, but net profit down 23% on tax and market pressures.SUM
H1 202413 Jun 2025 - Record profit, strong sales, and expansion delivered despite market headwinds.SUM
H2 20245 Jun 2025